Suchergebnisse - "IgG"

PubPharm (7)

1

Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro

enthalten in: mAbs | 2024

von Qureshi, O. | Sutton, E. | Bithell, R. | +10

2

Selection of bispecific antibodies with optimal developability using FcRn‑Ph‑HPLC as an optimized FcRn affinity chromatography method

enthalten in: mAbs | 2023

von Müller, T. | Tasser, C. | Tesar, M. | +4

3

Changes in complementarity-determining regions significantly alter IgG binding to the neonatal Fc receptor (FcRn) and pharmacokinetics

enthalten in: mAbs | 2018

von Piche-Nicholas, N. | Avery, L. | King, A. | +5

4

Utility of a human FcRn transgenic mouse model in drug discovery for early assessment and prediction of human pharmacokinetics of monoclonal antibodies

enthalten in: mAbs | 2016

von Avery, L. | Wang, M. | Kavosi, M. | +12

5

A novel in vitro assay to predict neonatal Fc receptor-mediated human IgG half-life

enthalten in: mAbs | 2015

von Souders, C. | Nelson, S. | Wang, Y. | +3

6

Combined glyco- and protein-Fc engineering simultaneously enhance cytotoxicity and half-life of a therapeutic antibody

enthalten in: mAbs | 2014

von Monnet, C. | Jorieux, S. | Souyris, N. | +10

7

A novel approach to investigate the effect of methionine oxidation on pharmacokinetic properties of therapeutic antibodies

enthalten in: mAbs | 2014

von Stracke, J. | Emrich, T. | Rueger, P. | +11

1
[1]